|Videos|May 30, 2023
CAR-T Cell Therapies Entering the Mainstream of Cancer Clinical Trials & Treatment
Author(s)Medidata
KEY LEARNING OBJECTIVES
- Audience will have an understanding how Medidata can have an impact with Clinical Trial pharma and bio tech firms that are working in this therapeutic area
- What are the challenges that CAR-T developers face and how can data help address those challenges
- How is Medidata AI “data” different from other data providers
Related Content
Trending on Pharmaceutical Technology
1
European Regulators Prepare the Pharma Industry for Future Changes as Legislation is Formalized
2
Technology Transfer: Success Drivers and Obstacles Explained
3
Assessment of Silicone Oil Cleaning on Indirect Surfaces in Aseptic Manufacturing
4
Why Oral Solid Dosage Validation Is a Business Continuity Function, Not Just a Compliance Requirement
5